• Publications
  • Influence
Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer.
For head and neck cancer, PET-guided dose escalation appears to be well-tolerated, and the maximum tolerated dose was not reached at the investigated dose levels.
E‐cadherin/catenin/cytoskeleton complex: A regulator of cancer invasion
Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer.
IMAT plans are deliverable within a 5-10-minute time slot, and result in a lower dose to the SB than 3D plans, without creating significant underdosages in the PTV, and PGD showed that IMAT delivery is as accurate as 3D delivery.
Definition and delineation of the clinical target volume for rectal cancer.
PURPOSE Optimization of radiation techniques to maximize local tumor control and to minimize small bowel toxicity in locally advanced rectal cancer requires proper definition and delineation
Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
High-dose IMRT for recurrent and second primary head and neck cancer in previously irradiated territory leads to approximately 20% long-term survival in a non-selected patient population.
Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update.
IMRT for sinonasal tumors provides low rates of radiation-induced toxicity without blindness with high local control and survival, and could be considered as the treatment of choice.
Cancer-Associated Fibroblasts Connect Metastasis-Promoting Communication in Colorectal Cancer
This review applies the metastasis-promoting communication of colorectal CAFs to 10 cancer hallmarks described by Hanahan and Weinberg to re-explore the potential messages implicated in this process.
Whole abdominopelvic radiotherapy (WAPRT) using intensity-modulated arc therapy (IMAT): first clinical experience.
IMAT was shown to be deliverable in an acceptable time slot and to produce dose distributions that are more homogeneous than those obtained with a CONV plan, with at least equal sparing of the OARs.
Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit
Starting chemotherapy in the ICU for a life-threatening malignancy related complication can be lifesaving even when infection or organ failure is present.
Anastomotic complications after Ivor Lewis esophagectomy in patients treated with neoadjuvant chemoradiation are related to radiation dose to the gastric fundus.
In patients undergoing neoadjuvant CRT followed by Ivor Lewis esophagectomy, the incidence of AC is related to the RT dose on the gastric fundus but not to the dose received by the proximal esophagus.